PROF Profound Medical Corp.
Healthcare$6.83-2.01%ClosedMarket Cap: $206.7M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
4.42
P/S
10.43
EV/EBITDA
-4.50
DCF Value
$-25.94
FCF Yield
-18.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
70.6%
Operating Margin
-194.0%
Net Margin
-199.4%
ROE
-75.6%
ROA
-57.0%
ROIC
-60.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $5.3M | 71.8% | $-7.9M | $-7.0M | $— | — |
| Q4 null | $6.1M | 66.8% | $-7.5M | $-8.3M | $— | — |
| FY null | $16.4M | 70.8% | $-42.0M | $-43.3M | $— | — |
| Q3 null | $5.3M | 74.3% | $-8.9M | $-8.0M | $— | — |
| Q2 null | $2.2M | 73.2% | $-14.0M | $-16.0M | $— | — |
| Q1 null | $2.6M | 70.7% | $-11.1M | $-10.7M | $— | — |
| Q4 null | $5.3M | 68.1% | $-82.5M | $-7.7M | $— | — |
| FY null | $10.2M | 65.9% | $-31.5M | $-26.5M | $— | — |
| Q3 null | $3.8M | 63.8% | $12.2M | $-12.7M | $— | — |
| Q2 null | $2.2M | 63.6% | $-7.8M | $-6.9M | $— | — |
| Q1 null | $1.4M | 60.2% | $-7.9M | $-6.6M | $— | — |
| Q4 2023 | $2.7M | 49.2% | $-64.2M | $-11.5M | $-0.42 | — |